Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.49 |
| ▸ | MGLL | Q99685 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.42 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.42 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7561059 | 1.00 | DGKA (0.53) | DGKAL3MBTL1ALDH1A1KDM4EDUSP3 | |
| SCHEMBL16800412 | 0.94 | DGKA (0.62) | DGKAL3MBTL1ALDH1A1KDM4EDUSP3 | |
| SCHEMBL6052685 | 0.94 | DGKA (0.62) | DGKAL3MBTL1ALDH1A1KDM4EDUSP3 | |
| SCHEMBL505106 | 0.94 | DGKA (0.62) | DGKAL3MBTL1ALDH1A1KDM4EDUSP3 | |
| SCHEMBL6052723 | 0.94 | DGKA (0.62) | DGKAL3MBTL1ALDH1A1KDM4EDUSP3 | |
| SCHEMBL28292733 | 0.92 | DGKA (0.61) | DGKAL3MBTL1ALDH1A1KDM4EDUSP3 | |
| SCHEMBL28131647 | 0.92 | DGKA (0.63) | DGKAL3MBTL1ALDH1A1KDM4EDUSP3 | |
| SCHEMBL16830136 | 0.90 | DGKA (0.58) | DGKAL3MBTL1ALDH1A1KDM4EDUSP3 | |
| Propene SCHEMBL11588452 | 0.87 | DGKA (0.54) | DGKAL3MBTL1ALDH1A1KDM4EDUSP3 | |
| SCHEMBL19817389 | 0.86 | DGKA (0.55) | DGKAL3MBTL1ALDH1A1KDM4EDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 997 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151957-A1 | FORSKOLIN AND METHODS OF USE THEREOF FOR PREVENTING OR TREATING OBESITY AND/OR METABOLIC DISEASES OR DISORDERS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2024-07-18 | — | — | WO | claimed |
| CN-118267354-A | Ibutinib composition and preparation method thereof | 湖南慧泽生物医药科技有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118121615-A | Nano-crystal composition containing cynara scolymus glucoside as well as preparation method and application thereof | 石河子大学第一附属医院 | 2024-06-04 | — | — | CN | claimed |
| CN-115192522-B | Composition containing ibutenib, and preparation method and application thereof | 烟台慧暄医药科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-118045064-A | Desloratadine oral-dissolving film composition, preparation method and application thereof | 上海云晟研新生物科技有限公司 | 2024-05-17 | — | — | CN | claimed |
| CN-116473923-B | Nalatinib solid dispersion composition and preparation method and application thereof | 杭州剂泰医药科技有限责任公司 | 2024-05-14 | — | — | CN | claimed |
| CN-117959252-A | Compositions of ropivacaine or a pharmaceutically acceptable salt thereof and uses thereof | 南京清普生物科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-115778906-B | Astaxanthin liposome and preparation method and application thereof | 温州医科大学 | 2024-04-26 | — | — | CN | claimed |
| CN-117919370-A | Pharmaceutical composition of peptidomimetic compound and application thereof | 石药集团中奇制药技术（石家庄）有限公司 | 2024-04-26 | — | — | CN | claimed |
| WO-2024078283-A1 | CRISABOROLE OR PHARMACEUTICALLY ACCEPTABLE SALT AQUEOUS SOLUTION COMPOSITION THEREOF | 海南普利制药股份有限公司 | 2024-04-18 | — | — | WO | claimed |
| WO-2007064084-A1 | GRANULES CONTAINING PRANLUKAST AND PROCESSES FOR THE PREPARATION THEREOF | YUHAN CORPORATION (KR) | 2007-06-07 | — | — | WO | claimed |
| WO-2007064083-A1 | SPRAY-DRIED GRANULES AND PROCESSES FOR THE PREPARATION THEREOF | YUHAN CORPORATION (KR) | 2007-06-07 | — | — | WO | claimed |
| CN-1957936-A | Silybin tiny pellets and preparation method | ANHUI CHINESE MEDICINE COLLEGE (CN) | 2007-05-09 | — | — | CN | claimed |
| CN-1951370-A | Method for preparing solid dispersible minipills of Simvastatin | ANHUI MODERN CHINESE MEDICINE (CN) | 2007-04-25 | — | — | CN | claimed |
| CN-1951385-A | Minipills containing simvastatin and derivative thereof and method for preparing formulation thereof | ANHUI MODERN CHINESE MEDICINE (CN) | 2007-04-25 | — | — | CN | claimed |
| EP-1765367-A1 | PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR PREPARATION AND USE | Chen, Andrew-Xian (US) | 2007-03-28 | — | — | EP | claimed |
| US-20060251713-A1 | Amino acid sequences capable of facilitating penetration across a biological barrier | CHIASMA, INC. (US) | 2006-11-09 | — | — | US | claimed |
| US-20060024341-A1 | Microemulsion composition and related method | BIOTEST LABORATORIES, LLC | 2006-02-02 | — | — | US | claimed |
| WO-2006002050-A1 | PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR PREPARATION AND USE | ENCORE THERAPEUTICS, INC. (US) | 2006-01-05 | — | — | WO | claimed |
| US-20050287180-A1 | Phospholipid compositions and methods for their preparation and use | ENCORE THERAPEUTICS, INC. | 2005-12-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060251713-A1 | Amino acid sequences capable of facilitating penetration across a biological barrier | SLC7A1, SLC1A5, SLC3A2 | DGKA 3195/4885L3MBTL1 2192/4885ALDH1A1 4531/4885 |
| US-20060024341-A1 | Microemulsion composition and related method | LIPA, SGMS1, SGMS2 | DGKA 511/4885L3MBTL1 4674/4885ALDH1A1 4699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.